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ABSTRACT  Vascular  smooth  muscle cells (VSMC) in the rat mesenteric artery show specific 
immunofluorescent  staining with antisera against purified  human uterine myosin (ASMM) but 
not  human platelet  myosin (APM). However,  in  primary  cultures  produced  by  enzymatic 
dissociation of this vessel, VSMC stain specifically with both ASMM and APM within 5 h after 
plating and throughout growth  to confluence  (4-10 d).  In confluent  cultures, APM staining 
remains bright while ASMM staining is reduced in intensity in most cells. In contrast, cellular 
myosin  content,  determined  by  quantitative  SDS  PAGE, is  comparable  in  confluent  and 
growing cultures. Immunoprecipitation  of high salt extracts of cultured VSMC with ASMM and 
APM yields myosins with the same mobilities on SDS PAGE. When serial, exhaustive precipi- 
tations are performed with one antiserum, followed  by reprecipitation  with the other, myosin 
in subconfluent and confluent VSMC cultures is exhaustively precipitated by either antiserum, 
thus indicating complete immunological cross-reactivity. These results might be explained by 
synthesis of  a  new  myosin isoform reactive with  both  ASMM and  APM. However,  the 
development  of APM staining in cultured VSMC did not require protein synthesis. Therefore, 
it  is  more  likely  that  the changes in  immunofluorescent  staining observed in  vitro  reflect 
conformational  alterations, perhaps related to cytoskeletal rearrangements. These changes in 
myosin antigenic expression may be relevant to the problem of VSMC phenotypic modulation 
both in vitro and in vivo. 
Our laboratory has been engaged in developing a functional 
culture model for the vascular smooth muscle cells (VSMC) ~ 
of muscular, resistance-type arteries. Primary rat mesenteric 
artery VSMC  cultures,  obtained by enzymatic dissociation 
(13), retain many of the biochemical characteristics of VSMC 
in the intact vessel. These differentiated functional properties 
include the presence of specific angiotensin lI (All) receptors 
(13) and dose-dependent All-induced phosphorylation of the 
20,000-dalton myosin light chain (1).  Physiological doses of 
~Abbreviations used in  this  paper:  ASMM, antismooth  muscle 
myosin; APM, antiplatelet myosin; F-GAR, fluorescein-labeled  goat 
anti-rabbit  lgG;  ~2Sl-B-H, monoiodinated  Bolton-Hunter  reagent; 
NRS, normal rabbit serum; VSMC, vascular smooth muscle cells. 
All can cause cellular contraction (reversible, agonist-specific 
cell shape change) in a variable but significant proportion of 
these cells (13). Thus, it appears that important biochemical 
steps in receptor activation-contraction coupling continue to 
be expressed in  vitro.  These cultured  VSMC  are,  however, 
"phenotypically modulated" according to some criteria (see 
reference 5). For example, they lack ultrastructurally demon- 
strable myosin-containing (12-18-nm diam) thick filaments, 
and exhibit increased proliferative and biosynthetic activities, 
prominent cytoplasmic stress fibers and cellular hypertrophy 
(13). 
As an approach to understanding the interrelationship of 
retained biochemical characteristics and those alterations im- 
posed  by  culture  conditions,  we  have  been  studying  the 
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etal protein (for a recent review, see reference  12) in VSMC, 
using immunofluorescent and immunochemical techniques. 
We have used antisera raised against purified human smooth 
muscle (uterine myometrial) and nonmuscle (platelet) myo- 
sins,  which show cell type-selective  immunofluorescence  in 
frozen sections of various tissues (17-19).  For example, the 
antiuterine  myosin  selectively  stains  visceral  and  vascular 
smooth muscle, including the medial layer of rat mesenteric 
artery.  In  contrast,  the  antiplatelet  myosin  does  not  stain 
medial VSMC in the mesenteric artery but does stain intimal 
endothelial cells in this vessel, as well as a variety of connective 
tissue and epithelial cells.  Using these immunologic reagents, 
we  have  characterized  both  qualitative  and  quantitative 
changes  in  myosin  antigenic  expression  that  occur  in  rat 
mesenteric artery VSMC during their adaptation to in vitro 
culture conditions. These in vitro changes may be relevant to 
the process of phenotypic modulation as it occurs in vivo in 
certain disease states involving vascular smooth muscle such 
as atherosclerosis or hypertension (5). 
MATERIALS  AND  METHODS 
Antisera:  The rabbit antiserum against human platelet myosin (purified 
according to Pollard et al. [23]) has been described previously (8) and is specific 
for the rod portion of this nonmuscle myosin type.  In Ouchterlony  double 
diffusion, this antiserum  cross-reacts with extracts of human uterine myome- 
trium (22); therefore, it was extensively absorbed with purified uterine myosin 
until immunofluorescent  staining of frozen sections of  visceral (rat tracheal and 
duodenal)  smooth muscle was lost. All experiments  reported  here employed 
the absorbed  antiplatelet  myosin (APM).  We have further  characterized  the 
reactivity of APM by immunofluorescence  microscopy on frozen sections of a 
variety of mammalian tissues ( 17, 19). In general, APM stains platelets, vascular 
endothelial,  epithelial (renal, intestinal,  tracheal), and connective tissue cells, 
but not cardiac,  skeletal, or visceral smooth muscle  or the vascular smooth 
muscle in muscular arteries, arterioles, or veins (cf. 7, 12). In contrast, however, 
APM does specifically label the smooth muscle of elastic arteries in all species 
tested (rat, calf, guinea pig, human). 
Antismooth muscle myosin (ASMM) was raised in rabbits against human 
uterine myosin purified by slight modifications of  the protocol cited above (23). 
In immunodiffusion,  ASMM  forms a  single precipitin  line  with extracts  of 
human uterus but not with extracts of human platelets or cardiac or skeletal 
muscle (22). ASMM  is also specific for smooth muscle  myosin heavy chain 
(200 kd) as shown by Western blot tests of rat aortic smooth muscle peptides 
separated by SDS PAGE under reducing conditions  (19). In immunofluore~ 
cence microscopy on frozen sections, ASMM stains all visceral and vascular 
smooth muscle tested, but no other cell type, including epithelial and connective 
tissue cells and skeletal and cardiac muscle (17, 19). 
Ctlltured  Ceils:  Rat mesenteric artery smooth muscle cells were iso- 
lated and cultured as previously reported (13). Briefly, male C-D strain Sprague- 
Dawley rats (225-250  g) were killed by cervical dislocation and the superior 
mesenteric  arterial  arcade  was aseptically excised. Fat,  adventitia,  and veins 
were removed by blunt dissection and the remaining arterial tree was incubated 
with elastase, collagenase, soybean trypsin  inhibitor,  and bovine  albumin at 
37"C in a  gyratory  shaker  bath.  After  repeated  tituration  and  sieving, the 
resulting cell suspension was washed by centrifugation and plated in Dulbecco's 
modified  Eagle's medium with  10%  calf serum, 2 mM L-glutamine, 25  mM 
HEPES  buffer,  100  U/ml penicillin,  and  0.1  mg/ml streptomycin  (M.  A. 
Bioproducts, Walkersville, MD). Similar methods were used for production  of 
rat aortic smooth muscle cultures by enzymatic dissociation. 
The cells were normally plated at a density of ~5 x  103 viable cells/cm 2 in 
plastic culture dishes (Falcon Plastics, Oxnard, CA) or on glass coverslips that 
had  been  precoated  with  human fibronectin  (Collaborative  Research,  Inc., 
Lexington, MA; 5 ~g/cm  2, air-dried from aqueous  solution). Fibronectin-coated 
coverslips were used for increased cell adhesion; this treatment had no apparent 
effect on growth  or staining  patterns.  Cultures  were incubated  at 37"C in a 
humidified atmosphere of 5% CO2/95% air with thrice weekly media changes. 
Explant outgrowth smooth muscle cell cultures were established, following 
the method reported by Ross (24), on fibronectin-coated coverslips and cultured 
as described above. A strain  of bovine aortic endothelial  cells, used for com- 
parison purposes, was originally isolated by collagenase digestion and charac- 
terized by standard  methods (10). 
Indirect Immunofluorescent Staining:  Smooth muscle cells on 
coverslips were rinsed briefly in phosphate-buffered saline (PBS: 0.15 M NaCI, 
10 mM Na2HPO4, 3 mM NaNs, pH 7.4), treated with acetone at 4°C (3 x 45 
s), and air-dried. Coverslips were used immediately for immunofluorescence  or 
stored, desiccated, at 4°C until use. Storage for at least 2 mo had no appreciable 
effect on staining intensity or pattern nor did other preparative protocols tested 
(formalin/Triton  X  100; formalin/acetone;  methanol/acetone;  acetone  at 
-20"C). 
Acetone-treated cells on coverslips were incubated  for 30 min at 37"C with 
ASMM, APM,  or control  sera (see below) at a  1:100 dilution  in PBS. They 
were washed for 15 min (three changes) in PBS, incubated with a 1:100 dilution 
of goat-anti-rabbit  IgG labeled  with  fluorescein  (F-GAR;  Miles-Yeda, Ltd., 
Rehovot,  Israel), washed again in PBS, rinsed briefly in deionized water, and 
mounted on glass slides using glycerol/PBS. 
lmmunofluorescent staining was examined  under epifluorescent illumina- 
tion (100 W Mercury) on a Leitz Orthoplan microscope with Leitz L-2 filter 
block. A 63 × Zeiss Planapo (NA 1.4; oil) and a 25 x Zeiss Plan-Neofluar (NA 
0.8;  oil) objective  lens  were used  for both fluorescence and phase  contrast 
microscopy. Time-exposure micrographs were taken for comparison of relative 
fluorescence intensities  using Kodak  Tri-X  film pushed  to an effective ASA 
1200 with Acufine developer (Acufine, Inc., Chicago, IL) and processed under 
standardized conditions. 
As controls  for specificity of staining, cells were incubated  with (a) preim- 
mune or normal rabbit serum (NRS, M. A. Bioproducts) followed by F-GAR; 
(b) no first antibody  then F-GAR; (c) first antibodies  but no F-GAR; (d) no 
antibodies; (e) ASMM and APM  followed by fluorescein-conjugated  normal 
goat serum; (/') ASMM that had been preabsorbed with uterine myosin, then 
F-GAR; (g) APM  that had  been  preabsorbed  with platelet  myosin,  then F- 
GAR; and (h) ASMM and APM followed by F-GAR that had been preabsorbed 
with NRS. None of these control  treatments  resulted in positive staining of 
VSMC in vivo or in vitro. 
Immunochemistry:  Myosin was metabolically labeled by incubating 
cultures with [35S]methionine  (0.5 mCi in 3 ml medium/100-mm diam culture 
dish; New England Nuclear, Boston, MA; specific activity  1,000 Ci/mmol) in 
methionine-free medium (RPMI- 1640) with 10% dialyzed (against Dulbecco's 
PBS) fetal calf serum for 12-18  h at 37"C. Cultures  were washed in Hank's 
balanced  salt solution  (Ca  *+- and Mg++-free) at 4"C to remove  extracellular 
label. Cells were scrape-harvested in 0.5 ml of extraction  buffer (0.5 M NaCI; 
0.5 mM EDTA; 0.5 mM dithiothreitol  (DTT);  30 mM Tris, pH 7.5; 0.1  mg/ 
ml BSA (Pentex ~, Miles Laboratories, Naperville, IL); and 0.1  t,g/ml phenyl- 
methylsulfonyl  fluoride (PMSF); as modified  from Scordilis et al.  [26]), dis- 
rupted in a Dounce homogenizer on ice, and cleared of particulates by centrif- 
ugation at 100,000 g for 1 h at 4"C. In preliminary experiments, this extraction 
protocol yielded a mean recovery (supernatant)  of 70 ±  17% (SD) of the total 
cellular myosin (as judged by comparison of supernatant and pellet fractions 
on quantitative  SDS PAGE, as below). Recovery was not significantly greater 
when 10 mM ATP was added  to the extraction  buffer. Other unlabeled  cell 
extracts, prepared  as above (extraction  buffer without dithiothreitol,  BSA, or 
Tris and with 50 mM borate buffer), were radioiodinated  for 1 h on ice with 
monoiodinated  Bolton-Hunter  reagent (~25I-B-H; New England Nuclear,  Bos- 
ton, MA; 2,000 Ci/mmol). After the iodination  step, DTT, BSA, and Tris were 
added to the same final concentration  as in the original extraction buffer. 
Purified uterine and platelet myosins were iodinated using '"I-B-H in a high 
salt buffer (0.6 M NaCI; 1 mM dithiothreitol; 0.1 mM MgCI2; 10 mM Imidazole, 
pH 7.0) at a B-H:myosin molar ratio of 2:l  (0.250 mCi 1251-B-H added  to 13 
ug myosin at 0.5-1.0  mg/ml). 
Myosin,  labeled with  3sS or  ~251, was immunoprecipitated  from the  cell 
extracts at room temperature  (compare reference 1) using ASMM, APM, and 
heat-killed, formalin-fixed Staphylococcus aureus (15). To reduce nonspecifi- 
cally precipitating  material,  purified  myosins and cellular  extracts were first 
cleared by a preimmune or normal serum precipitation  (0.I ml serum/0.5 ml 
extract  for 90 min followed by incubation  with the packed equivalent  of 0.2 
ml  of a  10%  S.  aureus  suspension  for 45  min,  and  centrifugation).  The 
supernatants were divided  into  three  equal  aliquots  and then reprecipitated 
with specific antisera (ASMM or APM) or NRS (0.05 ml serum/aliquot for 60 
min followed by the packed equivalent of 0.1  ml ofS. aureus for 30 min). To 
avoid myosin solubility problems at low ionic strengths, 3 M NaCI was added 
to all sera to increase the molarity to 0.5 M. The pellets were washed repeatedly 
by centrifugation:  twice with NET buffer (140 mM NaCI; 5 mM EDTA; 50 
mM Tris, pH 7.3; 0.02% NaNs; 0.5% NP40) supplemented  with 0.5 M NaCI, 
twice with NET buffer supplemented  with 0.25 M NaCI, and twice with NET 
buffer. The final pellets were boiled directly in 2 x Laemmli sample buffer for 
SDS PAGE (16). 
Samples were electrophoresed on Laemmli  SDS PAGE gels (7-15%  linear 
acrylamide  gradient)  that were subsequently  fixed with trichloroacetic  acid/ 
sulfosalicylic acid/methanol (30). [aSS]labeled gels were treated  with the gel 
fluor solution  En3Hance (New England  Nuclear).  Dried  gels were autoradi- 
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omat AR film which was developed by an X-omat automatic processor. 
Quantitation of Myosin Content of VSMC:  Myosin  content  of 
VSMC was determined by densitometry of  Coomassie  Blue stained gels. Freshly 
isolated,  washed pellet  cells were  suspended in 2  x  Laemmli sample buffer, 
sonicated, and boiled for 3 min. Cultured cells were washed twice with Hank's 
balanced salt solution (Ca  ++- and Mg*+-fr~) and serape-harvested. Pellets  of 
these cells were solubilized in 2 x  sample buffer as above. 
Samples were run reduced on Laemmli SDS PAGE gels (6% -acrylamide), 
fixed, and stained with Coomassie Blue R-250 (1% with trichloroacetic acid, 
sulfosalicylic acid in 30% methanol; [30]) and destained in 10% 2-propranol/ 
10%  acetic acid.  After destaining, gels were incubated in  1%  glycerol/10% 
acetic  acid  for  30-45  rain,  and  dried,  under  vacuum, between  sheets of 
cellophane (Bio-Rad Laboratories, Richmond, CA). Dried gels were  scanned 
in an LKB Bromma 2202 Ultrosean laser densitometer. Myosin content (heavy 
chain only) was quantitated by comparison with a  standard curve based on 
densitometry of known amounts of rabbit  skeletal  myosin (Sigma M1636, 
Sigma Chemical Co., St. Louis, MO; additionally purified by precipitation by 
dialysis against distilled water) run in parallel  gel lanes. For comparisons of 
myosin content at different times in culture, cdlular DNA and total protein 
assays were carried out on parallel  cultures or pellets of freshly isolated cells. 
DNA determinations were made by the technique of Cesarone et al. (3) with 
33258 Hoechst dye and protein was determined by the method of Lowry et al. 
(20). The DNA assay was used as an indication of  cell number in these studies. 
In preliminary experiments on both growing and confluent cultures, the cor- 
relation coefficients  of linear regression between DNA content and hemacy- 
tometer cell counts were >0.9. 
RESULTS 
Immunofluorescent Staining 
As we have reported previously (17,  19), vascular smooth 
muscle cells  in the media of the rat mesenteric artery show 
specific immunofluorescent staining with ASMM but not with 
APM  (Fig.  l).  However, when these  cells were isolated by 
enzymatic dissociation  and  plated  in  culture,  they  rapidly 
acquired reactivity for the "non-muscle-specific" antiserum, 
APM.  By 5 h  in primary culture, all cells  stained with both 
ASMM  and  APM  in  a  punctate,  fibriUar pattern  (Fig.  2). 
These brightly staining particles, which resembled those re- 
ported by Gr6schel-Stewart et al. (11),  were often aligned in 
linear arrays, arranged circumferentially or radially. After 1- 
2 d  in  culture,  staining with both antimyosins (Fig.  2)  was 
localized in structures corresponding to stress fibers as visu- 
alized  by phase  contrast  microscopy (Fig.  3).  These  stress 
fibers were found to  stain with either antiserum  suggesting 
co-localization of ASMM  and  APM  reactivity within  these 
microfilament  bundles.  Preimmune  sera,  normal  rabbit 
serum, and preabsorbed antisera (see Materials and Methods) 
did not stain any of these cultured VSMC. In addition, as a 
cellular control for antisera specificity and fixation artifacts, 
we examined cultured  bovine aortic endothelial  cells using 
ASMM  and  APM.  The  staining  of these cells retained the 
staining pattern seen in vivo (Fig.  1): staining with APM was 
bright whereas ASMM did not stain (Fig. 4D). 
Cells in subconfluent primary cultures stained brightly and 
specifically with both ASMM and APM at all times examined, 
as illustrated in  Fig. 2.  However, at confluence, most of the 
cells showed reduced staining with ASMM (although still  in 
a  specific,  fibrillar pattern),  while  only a  small  proportion 
retained the previous bright labeling (Fig. 2), thus giving rise 
to a "mosaic" appearance. In contrast, the reaction with APM 
continued to be bright, specific, and fibrillar in all cells (Fig. 
2).  The  same temporal sequence  was also seen in  primary 
cultures of VSMC obtained by enzymatic dissociation of rat 
aorta.  In  addition,  primary cultures  of bovine and  canine 
coronary artery VSMC, isolated by the same method, showed 
a similar staining pattern (Larson, D., P. Miao, and P. Libby, 
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FIGURE  1  Immunofluorescence  micrographs  of myosin  staining in 
frozen sections  (3 pro) of rat mesenteric  artery.  (a) ASMM staining 
in medial smooth muscle cells; (b) APM staining of intimal endothe- 
lial cells (arrowhead) but not medial smooth muscle  cells  (double 
arrow indicates width of medial  layer);  (c) phase-contrast  micro- 
graph of a; (d) phase-contrast  micrograph of b. Bar, 50 #m; × 280. 
unpublished observations). 
In mesenteric artery VSMC, the shift to the mosaic staining 
pattern at confluence was independent of plating density and 
hence time in vitro. These cells begin to show mitotic activity 
at ~60 h in culture. When we examined cultures that became 
confluent after one population doubling (at 4 d), the staining 
pattern was indistinguishable from that in cultures reaching 
confluence after approximately six population doublings (10 
d). 
After a  given primary culture of rat mesenteric artery or 
aortic  VSMC  reached  confluence,  the  staining  pattern  de- 
scribed above was retained throughout postconfluent growth 
and persisted in  subsequent subcultures.  In addition,  when 
cultures were prepared by the explant-outgrowth technique, 
bovine aortic (Fig. 4A), rat aortic (Fig. 4B), and rat mesenteric 
artery (Fig.  4 C) VSMC displayed a similar staining pattern, 
viz., uniformly intense staining with APM in all ceils, specific 
but reduced staining with ASMM in most cells,  and bright 
staining  with  ASMM  only in  occasional cells.  In  fact,  the 
initial halo of cells migrating from explanted fragments of rat 
aortic media showed the same staining pattern. 
Immunochemistry 
The change in myosin antigenic expression (as detected by 
immunofluorescent  staining)  from the  in  vivo to  in  vitro 
states in rat mesenteric artery VSMC, and the variable anti- 
genic expression of myosin in cultured VSMC, suggested that 
an alteration was occurring in this cytoskeletal component as 
the  cells became adapted to  culture  conditions.  To  further 
define these culture-related changes, we used immunochemi- 
cal methods to better characterize the myosins expressed by 
cultured VSMC. 
When high-salt extracts of subconfluent or confluent, met- 
abolically-labeled, rat mesenteric artery VSMC cultures were 
immunoprecipitated with ASMM  or APM,  each antiserum FIGURE 2  Immunofluorescence  micrographs of myosin staining in cultured, enzymatic dissociation, rat mesenteric artery smooth 
muscle cells using ASMM (top) APM (middle and bottom) at 5 h in culture, in subconfluent culture, and in confluent culture. Bar, 
100/~m; x  140. The bottom row contains higher magnification  micrographs of APM staining. Bar, 50/~m; x  380. These photographs 
reflect the relative fluorescence intensities observed microscopically. 
precipitated  myosin selectively (Fig.  5).  The myosin recog- 
nized by both antisera ran as one heavy chain (Mr =  200 kd) 
and two light chains (Mr =  17 and 20 kd) of similar mobilities 
on  SDS  PAGE.  Treatment,  in  parallel,  of aliquots  of the 
culture extracts with control NRS did not result in precipita- 
tion of detectable myosin. A similar result was obtained with 
a nonimmunological precipitation of myosin from these high- 
salt extracts using purified rabbit skeletal muscle or chicken 
gizzard F-actin (prepared according to the method of Spudich 
and  Watt  [28]).  F-actin  precipitated  myosin  of the  same 
mobility on SDS PAGE in the absence but not in the presence 
of 10  mM ATP (data not  shown).  The above experiments 
relied on protein synthesis for radiolabeling and thus would 
not detect any myosin that was carried over from before the 
labeling period.  Therefore, we extracted unlabeled rat mes- 
enteric artery VSMC cultures, radioiodinated all of the pro- 
teins in these extracts using ~25I-Bolton-Hunter  reagent, and 
then immunoprecipitated with ASMM  and APM.  This ap- 
proach  gave essentially  the  same  results  as  obtained  with 
[3SS]methionine-labeled  cells,  one myosin heavy chain, and 
two light chains  of the  mobilities indicated  above on  SDS 
PAGE (data not shown). 
To determine whether the antisera used in this study could 
distinguish between different myosins in solution, we initially 
tested them against radioiodinated purified uterine and plate- 
let myosins (the original immunogens) in an exhaustive im- 
munoprecipitation protocol (Fig. 6A). Each myosin prepara- 
tion was repeatedly precipitated with one antiserum until no 
further myosin was removed from solution (Fig. 6A; lanes 1- 
4). The resultant supernatant was then reacted with the other 
antiserum (lane 5). Note that in this protocol, the critical tests 
for antigenic cross-reactivity are the cross-over precipitations 
(lane 5). Using this technique, we determined that each anti- 
serum could exhaustively precipitate its original immunogen. 
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methionine-labeled cultured rat mesenteric artery VSMC (Fig. 
6B),  both ASMM  and  APM  exhaustively precipitated the 
metabolically-labeled myosin (lanes  1-4),  so that  no addi- 
tional  myosin  was  precipitated by  subsequent  incubations 
with the other antiserum (lanes 5). This result was obtained 
with myosin extracted from both subconfluent and confluent 
VSMC cultures (Fig. 6 B). 
Myosin Content of Cultured VSMC 
To determine whether the myosin content of VSMC was 
altered during the course of primary culture, we  measured 
myosin in  these  cells  by quantitative  SDS  PAGE  and  gel 
scanning densitometry. To provide an estimate of  the amount 
FIGure  3  Immunofluorescence (a) and parallel phase-contrast (b) 
micrographs of cultured rat mesenteric artery smooth muscle cells. 
Note the co-linearity of stained (ASMM +  F-GAR) and phase-dense 
stress fibers. Bar, 50/~m; x  480. 
Thus,  APM  exhaustively  precipitated  platelet  myosin 
(ASMM, in lane 5, did not precipitate myosin after four serial 
precipitations with APM) but not uterine myosin. Similarly, 
ASMM  exhaustively  precipitated  uterine  myosin  but  not 
platelet  myosin.  Presumably,  the  reactivity of APM  with 
uterine (myometrial) myosin (lane 1) is due to the presence 
of nonmuscle cell myosin in this heterogeneous tissue prepa- 
ration (2, 22). 
To test the immunoreactivity of myosin in the tissue used 
for the VSMC cultures, rat mesenteric artery segments (dis- 
sected free of adventitia)  were  homogenized in  extraction 
buffer, and  the  extracted proteins radioiodinated and  sub- 
jected to serial  immunoprecipitation. Although the cellular 
heterogeneity of this tissue (endothelium, fibroblasts,  residual 
blood cells, in addition to VSMC) makes definitive interpre- 
tation of the results difficult, the great majority of cells in the 
sample were smooth muscle (vessel segments chosen were of 
the same size as those shown in Fig. 1). Interestingly, however, 
>50% of  the extracted myosin was precipitated by APM, thus 
suggesting  the presence of APM determinants in  VSMC in 
situ (data not shown). 
In contrast to the results obtained with the original immu- 
nogens and with myosin extracted from the vessel wall, when 
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FIGURE 4  Immunofluorescence micrographs  of  myosin  staining. 
(A-C) Confluent primary, explant-outgrowth, vascular smooth mus- 
cle cultures:  (A)  bovine aortic;  (B)  rat  aortic;  (C)  rat  mesenteric 
artery.  Note uniform staining with APM and  mosaic  pattern with 
ASMM. (D) Bovine aortic endothelial  cell culture. Note staining with 
APM but not with ASMM.  Bar, 50 #m; x  260. FIGURE  5  Gel autoradiography of immunoprecipitates from  high- 
salt  extracts  of  subconfluent  and  confluent  rat  mesenteric  artery 
smooth muscle cultures. Metabolically labeled myosin was precip- 
itated  using  ASMM  or  APM  and  run  reduced  on  SDS  PAGE  as 
described in the text. (Markers from parallel Coomassie Blue-stained 
lanes:  MHC,  myosin  heavy  chain,  Mr  =  200,000  mol  wt;  MLC, 
myosin light chains,  Mr =  20,000 and  17,000.)  Lanes labeled NRS 
are  parallel  precipitations  with  normal  rabbit  serum.  The  band 
migrating between the  17,000- and  20,000-moI-wt  MLC  (subcon- 
fluent, APM) was presumed to be a  partial  proteolytic product of 
the 20,000-moI-wt MLC since it varied in quantity from experiment 
to experiment and with the concentration of phenylmethylsulfonyl 
fluoride used. A similar band was also seen with ASMM precipitation 
and from confluent cultures in other experiments. 
of myosin present in VSMC in vivo, we used freshly isolated 
cells harvested by the enzymatic dissociation protocol. Cul- 
tured cells were prepared for gel samples at subconfluent (in 
log-phase growth) and confluent densities, in parallel with the 
cultures used for the immunofluorescence and immunochem- 
ical studies described above.  Multiple samples of cells,  dis- 
solved in sample buffer, were run on SDS PAGE gels for each 
culture time point. For each gel,  a  standard curve was con- 
structed  using  known  amounts  of rabbit  skeletal  myosin. 
Scanning densitometry of the  myosin heavy chain peaks in 
these  standards  yielded  correlation  coefficients  of  linear 
regression  of 0.986-0.997.  Interpolation on  these  standard 
curves then provided values for the  myosin content  of cell 
samples  run  in  parallel  lanes.  These  data,  normalized  for 
DNA  to  permit  comparison  at  different  time  points,  are 
presented in  Table I. Cellular myosin content in some sub- 
confluent cultures tended to be decreased from the baseline 
value calculated for freshly isolated cells, although the overall 
difference in the mean values is not statistically significant (P 
>  0.5).  In contrast, total protein DNA ratios were increased 
in both subconfluent and confluent cultures compared with 
freshly isolated cells, consistent with cellular hypertrophy (13). 
FIGURE  6  Gel  autoradiography of serial  immunoprecipitations  of 
radiolabeled myosins. (A)  Precipitations of radioiodinated purified 
platelet  and  uterine  myosins;  (B)  Precipitations  of  metabolically 
labeled ([35S]methionine) myosin from high-salt extracts of subcon- 
fluent and confluent rat mesenteric artery smooth muscle cultures. 
Each experimental sample was divided  into three equal  portions. 
One  was subjected  to a  control  precipitation  with  normal  rabbit 
serum  (NRS). The  remaining two  were  serially  precipitated  with 
ASMM or APM as noted (lanes 1-4). The resultant supernatants in 
each  case  were  then  reacted  with  the  contrasting antimyosin  as 
noted (lanes 5). Only those parts of the autoradiograms containing 
the  200,000-mol-wt  myosin  heavy  chain  are  shown.  Note  that 
partial degradation products of platelet myosin heavy chain are also 
immunoprecipitated. 
TABLE  I 
Total Protein and Myosin  Content of Freshly 
Isolated and Cultured Rat Mesenteric Artery VSMC 
Cell preparations*  Total protein*/DNA  s  Myosinl/DNA  s 
(n)  (+ SEM)  (+ SEM) 
Freshly isolated (6)  5.5 +  0.3  0.30 +  0.06** 
Subconfluent culture (5)  25.2 ±  6.0  ~**  0.10 ±  0.05  **sj 
Confluent culture (5)  20.6 ±  2.6  I**  0.13 ±  0.05  **sj 
* Freshly  isolated  cells  were collected at the  end  of the  enzymatic 
dissociation  protocol. Cells were plated at a standard density (=5 x 
103 viable cells/'cm  2) to achieve confluence at 6-8 d (5.9 -  1.6 (SEM) 
x  104 cells/cm2). Subconfluent cultures  were harvested  during log- 
phase growth after 4 d in culture (2.3 __. 0.6 (SEM) x  104 cells/cmZ), n, 
number of preparations. 
* Total protein was determined by the method of Lowry et al. (20) and 
is expressed in weight/weight ratios with  DNA for comparison  pur- 
poses. 
DNA  was determined by the  method of Cesarone et al.  (3). DNA 
content was proportional to cell number (see  Materials and Methods) 
and averaged 10.7 __. 2.4 pg per cell. 
I Myosin content was determined by SDS PAGE and scanning densito- 
metry and is expressed in weight/weight ratios with DNA for compar- 
ison  purposes.  Standard curves  were contructed for each  gel  from 
scanning densitometry of myosin heavy chain bands in parallel lanes 
containing known quantities  of rabbit skeletal myosin. Values for the 
mass of VSMC myosin were determined by interpolation on these 
curves assuming, as a first order approximation, that the quantities  of 
heavy chains were proportional to total myosin. 
Different from freshly isolated cells (Fisher's t distribution for unpaired 
variates; P <  0.01  ). 
~,**,H No significant  difference (at P =  0.05)  between values indicated by 
same symbol. 
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The purpose of this study was to characterize the antigenic 
expression of myosin in cultured rat mesenteric artery VSMC, 
cells which  retain  vasoactive hormone receptors and  other 
differentiated properties, including contractility, in vitro (13). 
We have demonstrated several changes in myosin antigenic 
expression during the  course of primary culture.  First,  the 
selective staining with  ASMM  expressed by medial VSMC 
(Fig.  1) in the rat mesenteric artry in situ was rapidly altered 
in vitro by the acquisition of staining with APM (Fig. 2). This 
dual staining was retained throughout growth to confluence 
(Fig.  2).  Second,  the  majority of immunofluorescently de- 
monstrable  myosin  in  cultured  cells  (Figs.  2  and  3)  was 
associated with punctate arrays and stress fibers, not the thick 
filaments typically  seen  in  vivo  (13,  27).  Finally,  ASMM 
staining  was  greatly reduced  in  intensity  in  most  cells  at 
confluence,  while  APM  staining (Fig.  2)  and  total myosin 
content was unchanged (Table I). 
Thus, we detected two major shifts in myosin immunoflu- 
orescent  staining  in  culture:  a  rapid  appearance  of APM 
staining following the initiation of culture and a diminution 
of ASMM staining at confluence. There are several potential 
explanations for the  de novo appearance of APM  staining 
(Fig. 2). One possibility is that the cultured VSMC make new 
myosin isoforms with different immunoreactivities. This ex- 
planation seems unlikely for two reasons. First, preliminary 
experiments, in which the freshly isolated VSMC were plated 
and cultured for 6 h in the presence of 0.1  mg/ml cyclohexi- 
mide (Sigma Chemical Co.; resulting in >95% inhibition of 
[35S]methionine  incorporation  into  trichloroacetic acid-pre- 
cipitable  material),  revealed  that  the  acquisition  of APM 
staining  was  not  dependent  on  protein  synthesis  (D.  M. 
Larson, unpublished observations). Hence, APM staining was 
unlikely to be due to de novo expression of  a different myosin 
isoform. Second, the complete cross-reactivity of ASMM and 
APM  in  immunoprecipitating myosins extracted  from the 
cultures (Fig. 6B) suggested that these antisera recognized the 
same molecular species in solution. This conclusion is rein- 
forced by the results obtained with confluent cultures. Since 
confluent VSMC stained heavily with APM (Fig. 2) and lightly 
with  ASMM,  discrimination  between  the  stained  species 
should  be  greatest  at  this  point  in  culture.  However, this 
difference was not reflected in  the immunoprecipitation of 
soluble, extracted myosin (Fig. 6 B). 2 
The most plausible explanation for the appearance of APM 
staining in the cultured cells is that APM-reactive antigenic 
determinants were present in situ, but masked. Two lines of 
evidence support this interpretation. First, the cycloheximide 
experiments indicated that protein synthesis was not required 
for APM reactivity. Second, the immunoprecipitation studies 
on myosin extracted from the rat mesenteric artery suggested 
that >50% of the precipitable myosin could be recognized by 
APM.  Although  the  vessel  preparations  contained  both 
2 Since the  extraction  protocol  used in  the  immunoprecipitation 
studies did not quantitatively solubilize the total cellular myosin (as 
seen in preliminary studies on confluent cultures), it is conceivable 
that a subpopulation of myosin, with a different antigenic reactivity, 
was not represented in solution. However, the wide variability in the 
proportion of  extractable myosin (50-82%) obtained under controlled 
conditions, and the lack of any detectable heterogeneity in the im- 
munoprecipitation  results, suggest that there was not, at least, any 
clearly defined insoluble subpopulation of myosin in these cells. 
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smooth muscle and nonmuscle cells (see Fig.  1), the quantity 
of myosin precipitated by APM strongly suggested the pres- 
ence of APM determinants in the smooth muscle cells in situ. 
This postulated masking of antigenic determinants might 
reflect differences in macromolecular assemblages of myosin 
in situ and in vitro (e.g., thick filaments vs. stress fibers). Such 
differences would presumably be abolished under dissociative 
conditions in solution, allowing the complete cross-reactivity 
seen  in  the  serial  immunoprecipitations from the  cultured 
cells. Whether the differences in immunoreactivity observed 
in  this  study are  related  to the  recently reported salt- and 
phosphorylation-dependent conformational alterations in sol- 
ubilized smooth muscle myosin monomers, from both gizzard 
(e.g.,  reference  14) and vascular (29) sources, remains to be 
studied. 
The other major alteration in myosin antigenic expression 
detected during the course of primary culture was the dimi- 
nution of ASMM staining at confluence. This shift appeared 
to be a  cell  contact  or density-related  phenomenon,  since 
neither the time elapsed in growth to confluence nor cumu- 
lative population doublings were significant factors. It is un- 
clear what effects cell contact might have on the expression 
of cytoskeletal elements in this system. Certainly, there was 
not  a  concomitant  dramatic  reduction  in  cellular  myosin 
content  at  confluence,  based  both  on  the  quantitative  gel 
analyses (Table I) and on the observation that APM staining 
remained uniform in intensity in all cells (Fig. 2). In addition, 
confluent cultures of rat mesenteric artery VSMC can phos- 
phorylate the 20 kd myosin light chain (1) and a substantial 
number of  these cells can contract in response to physiological 
doses of angiotensin  II (13).  The lack of direct correlation 
between ASMM-specific staining, phosphorylation, and cel- 
lular contraction suggests that myosin in certain altered anti- 
genic states is still capable of functional interactions with actin 
in this in vitro system. Whether the myosin must somehow 
be mobilized or shifted to a different conformation for this 
activity to occur is an interesting possibility. If  this hypothesis 
is correct, then it indicates that the functional defect(s) in the 
characteristically noncontractile VSMC cultures produced by 
explant-outgrowth  (which  share  the  same  myosin  staining 
pattern as confluent enzyme-dissociation VSMC; Figs. 2 and 
4A-C) may be a more proximal point in the cellular contrac- 
tile system, such as a lack of specific agonist receptors (com- 
pare with reference  13) or receptor-activation-response cou- 
pling. 
Chamley-Campbell and co-workers (4-6) have used rabbit 
antisera raised against gizzard smooth muscle myosin to study 
myosin expression in  cultured rabbit,  human,  and monkey 
VSMC. In their experience, cultured VSMC characteristically 
lose smooth muscle specific myosin staining at the onset of 
cell division and only variably regain it at confluency (de- 
pending on initial plating density). These observations formed 
one of the bases for their definition of "phenotypic modula- 
tion." In contrast, we have observed that ASMM staining in 
rat, bovine, and canine VSMC was retained at all times in 
culture and not lost during log-phase growth. In addition, our 
results indicated that there was no quantitative reduction in 
total cellular myosin in culture, but rather a shift in antigenic 
reactivity that was independent of  plating density. The reasons 
for the discrepancies between our results and those reported 
by Chamley-Campbell et al. are unclear, but may be related 
to the differences in species and antisera employed. Nonethe- 
less, our observations clearly indicate that changes in myosin antigenic expression are not necessarily a simple monitor of 
the  state  of "phenotypic  modulation"  in  cultured  vascular 
smooth muscle cells. 
Currently, there is much interest in alterations in contractile 
and  cytoskeletal  proteins  in  various pathological  processes 
(25)  and,  in  particular,  in  the modulation of intermediate 
filament  protein  expression  in  vascular smooth  muscle  in 
experimental models of atherosclerosis (9, 21). In the case of 
myosin expression in vivo, it is interesting that human aortic 
intimal VSMC,  in both diffuse intimal thickening and well 
developed fibromuscular plaques,  can be stained with both 
ASMM and APM (unpublished observations; [ 19]). Such cells 
have been considered to be an in vivo counterpart of pheno- 
typically modulated cultured VSMC (5,  6,  25).  Further un- 
derstanding of the factors regulating the expression ofantigen- 
ically altered states of myosin may help to better define the 
problem of"phenotypic modulation" in cultured VSMC, and 
also provide useful information on the cell biology and pa- 
thology of vascular smooth muscle cells in vivo. 
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